1-2 of 2
Edward Agura, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Relapse Risk Score to Predict Acute Myeloid Leukemia Relapse After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Based on Pre-Transplant Variables.

Boglarka Gyurkocza, M.D., Rainer Storb, M.D., Barry E. Storer, Ph., D., Thomas Chauncey, MD, Thoralf Lange, M.D., Ginna G. Laport, MD, Amelia Langston, M.D., Michael A. Pulsipher, M.D., Christopher Bredeson, M.D., Richard Maziarz, M.D., Benedetto Bruno, M.D., Finn Petersen, M.D., Michael Maris, M.D., Edward Agura, M.D., Andrew M. Yeager, M.D., Wolfgang A. Bethge, M.D., Firoozeh Sahebi, M.D., Frederick R. Appelbaum, M.D., David G. Maloney, M.D., Elihu H. Estey, M.D., Brenda M. Sandmaier, MD
Journal: Blood
Blood (2010) 116 (21): 3450.
https://doi.org/10.1182/blood.V116.21.3450.3450
Published: 2010
Journal Articles

Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Poor Risk, Relapsed or Refractory Multiple Myeloma.

George E. Georges, M.D., Michael B. Maris, M.D., Brenda M. Sandmaier, M.D., Judith Shizuru, M.D., Ph.D., Dietger W. Niederwieser, M.D., Edward Agura, M.D., Benedetto Bruno, M.D., Peter A. McSweeney8, M.D., Rainer F. Storb, M.D., David G. Maloney, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2756.
https://doi.org/10.1182/blood.V104.11.2756.2756
Published: 2004